DEBRA SCHULTZ: Open Payments
NPI 1124194279 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 24 payments from 11 companies in 2025. Trend: 2023 $193 · 2024 $406 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $152 |
| AstraZeneca Pharmaceuticals LP | 4 | $96 |
| Viatris Specialty LLC | 2 | $51 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| INOGEN, INC. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Electromed, Inc. | 1 | $20 |
| Insmed, Inc. | 1 | $20 |
Products named: TRELEGY ELLIPTA, NUCALA, FASENRA, YUPELRI, OPSUMIT, JASCAYD, DUPIXENT, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH.
Industry payments across MI — which companies pay providers there.
